You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.0 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 5.4 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-03-31 | n/a | -3.22 | -6.20p | -3.1 | 0.0 | n/a | n/a | 0.0% |
2017-03-31 | n/a | -3.64 | -4.13p | -5.3 | 0.0 | n/a | n/a | 0.0% |
2018-03-31 | n/a | -3.03 | -3.23p | -4.0 | 0.0 | n/a | n/a | 0.0% |
2019-03-31 | n/a | -3.12 | -2.70p | -7.1 | 0.0 | n/a | n/a | 0.0% |
2020-03-31 | n/a | -3.17 | -2.07p | -1.7 | 0.0 | n/a | n/a | 0.0% |
Evgen makes progress with recruitment in 'STAR' trial Sharecast News | 17 Feb |
---|---|
Evgen announces positive preclinical data for SFX-01 Sharecast News | 22 Jan |
Evgen reports 'highly positive' data from SFX-01 trial Sharecast News | 21 Jan |
Holding(s) in Company | 08-Mar-21 13:49 |
---|---|
Holding(s) in Company | 05-Mar-21 16:04 |
Director dealing | 05-Mar-21 09:17 |
Result of General Meeting & Total Voting Rights | 03-Mar-21 12:11 |
Result of Open Offer | 03-Mar-21 07:00 |